Characterizing LIN-12/Notch Regulation and Activity
Characterizing LIN-12/Notch Regulation and Activity
批准号:
9763328
负责人:
Katherine Luo
金额:
$4.29万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-15 至 2020-08-14
关键词:
AdultAllelesAnimalsCRISPR/Cas technologyCaenorhabditis elegansCell NucleusCell membraneCellsCleaved cellComplexDNA BindingDatabasesDevelopmentDevelopmental ProcessDiseaseEpidermal Growth Factor ReceptorExhibitsFutureGene Expression ProfilingGenesGenetic TranscriptionGenome engineeringGoalsGrowth FactorHuman DevelopmentImage AnalysisInsulinLife Cycle StagesLigandsLobular NeoplasiaMaintenanceMediatingMediator of activation proteinMethodsModelingMonitorNatureNotch Signaling PathwayNuclearNuclear EnvelopeNuclear RNAPatternPlayProcessProteinsRegulationResearchRoleSequence-Specific DNA Binding ProteinSignal PathwaySignal TransductionSpecific qualifier valueStem cellsSystemTestingTight JunctionsTimeTissue-Specific Gene ExpressionTissuesTranscription CoactivatorTranscriptional ActivationTranslationsVulvaWorkcancer stem cellcell fate specificationenv Gene Productsexperimental studyhuman diseaseimprovedin vivoinsightinsulin signalingnotch proteinnovelpluripotencyprecursor cellpreventquantitative imagingreceptorregenerative therapyresponsetranscription factortranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The life cycle of Caenorhabditis elegans contains a developmentally arrested state called dauer that occurs in
response to adverse environmental conditions. This dauer stage is a period of prolonged cellular quiescence
that is associated with not only the maintenance but also reprogramming of the Vulval Precursor Cells (VPCs)
into a multipotent state. Normally in development, VPC fate specification requires LIN-12/Notch, a well-
conserved transmembrane receptor and transcriptional activator, for transcriptional activation of target genes
to define the future cell identity. However, during dauer, this transcriptional activation is blocked, even in the
presence of a stable and activated LIN-12/Notch. Moreover, VPCs that had already undergone cell fate
specification by LIN-12/Notch are de-differentiated into a multipotent state upon dauer entry. This block is
mediated by Insulin/Insulin Growth Factor Signaling, as loss of its effector, the transcriptional factor DAF-
16/FoxO, results in a partial relief of the block. To study how dauer VPCs are able to prevent LIN-12/Notch
signaling, I will investigate how LAG-1, the DNA-binding component of the LIN-12/Notch activation complex, is
regulated in dauer VPCs, and I will test whether expressing stable and functional LAG-1 will relieve the dauer
block. I will also perform a differential gene expression analysis experiment between blocked and unblocked
dauer VPCs to look for candidates that may prove essential for maintaining VPCs in a quiescent and
multipotent state.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
海外基金